Apramitha Innovations Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 05-11-2024
- Paid Up Capital ₹ 0.10 M
as on 05-11-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 279.56%
(FY 2023)
- Profit -90.21%
(FY 2023)
- Ebitda -256.48%
(FY 2023)
- Net Worth -177.02%
(FY 2023)
- Total Assets -66.66%
(FY 2023)
About Apramitha Innovations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sree Gottimukkala and Venkata Sreedharala serve as directors at the Company.
- CIN/LLPIN
U24239TG2020PTC140565
- Company No.
140565
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jun 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Apramitha Innovations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sree Gottimukkala  | Director | 26-Aug-2020 | Current |
| Venkata Sreedharala | Director | 02-Jun-2020 | Current |
Financial Performance of Apramitha Innovations.
Apramitha Innovations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 279.56% increase. The company also saw a substantial fall in profitability, with a 90.21% decrease in profit. The company's net worth observed a substantial decline by a decrease of 177.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apramitha Innovations?
Unlock access to Apramitha Innovations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Avion Agricultural And Breeding Research Farms Pvt.Ltd.Active 39 years 2 months
Sree Gottimukkala is a mutual person
- Sarudbhava Formulations Private LimitedActive 12 years 1 month
Venkata Sreedharala is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Apramitha Innovations?
Apramitha Innovations has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apramitha Innovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apramitha Innovations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
